Our Pricing

Weight Loss Injection Cost - Lowest Price UK

Published on: June 03, 2026

Understanding weight loss injection cost UK pricing helps you make informed decisions about your treatment. At Cured Pharmacy, we offer transparent upfront pricing on all licensed weight loss injections — from Saxenda at £135.00 to Mounjaro at £135.00 — with prices shown before your free clinical consultation with a UK prescriber.

How Weight Loss Injection Cost UK Varies by Treatment Type

Weight loss injection pricing in the UK depends primarily on the active ingredient, dosing frequency, and clinical efficacy demonstrated in trials. GLP-1 receptor agonists like liraglutide (Saxenda) require daily injections, whilst newer dual-action treatments like tirzepatide (Mounjaro) work weekly, affecting overall cost structures [1].

At Cured Pharmacy, Saxenda starts from £135.00 Wegovy from £135.00 and Mounjaro from £135.00 per treatment cycle. These prices reflect the cost of UK-licensed medications dispensed following clinical assessment by our registered prescribers. All treatments are MHRA-approved and sourced through legitimate UK pharmaceutical supply chains [2].

The significant variation in weight loss injection cost UK pricing stems from differences in manufacturing complexity, patent protection, and clinical trial investment. Tirzepatide, for example, is the first dual GIP/GLP-1 receptor agonist licensed globally, representing a more advanced formulation than single-pathway alternatives [1].

Understanding Mounjaro Injection Costs and Clinical Value

Mounjaro (tirzepatide) represents the newest generation of weight loss injections available in the UK, priced from £135.00 at Cured Pharmacy. In the SURPASS-3 clinical trial, patients achieved an average 22.5% body weight reduction over 72 weeks on the highest dose — substantially greater than results seen with earlier GLP-1 treatments [1].

The once-weekly KwikPen delivery system reduces injection frequency compared to daily alternatives, which many patients find more convenient for long-term adherence. Each pen contains four pre-measured doses, and treatment typically begins at 2.5mg weekly before titrating upward based on individual response and tolerability [3].

Whilst Mounjaro carries a higher upfront cost than some alternatives, the dual-receptor mechanism may offer greater efficacy for suitable patients. Your UK prescriber will assess whether the clinical benefits justify the investment based on your medical history, previous treatment responses, and weight loss goals [1][3].

Who May Benefit Most from Mounjaro

Clinical guidance suggests tirzepatide may be particularly suitable for patients who have not achieved adequate results with single-pathway GLP-1 treatments, or those with a BMI over 35 who require more intensive pharmacological intervention. UK prescribers assess eligibility based on NICE guidance and individual clinical circumstances [3].

Wegovy and Saxenda: Comparing Semaglutide and Liraglutide Costs

Wegovy (semaglutide) and Saxenda (liraglutide) both work through GLP-1 receptor activation but differ in dosing frequency and clinical trial outcomes. Wegovy requires once-weekly injections and demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial, whilst Saxenda requires daily injections and showed average reductions of 8% over 56 weeks [2][4].

At Cured Pharmacy, Wegovy starts from £135.00 and Saxenda from £135.00. The lower cost of Saxenda reflects its earlier market entry and daily dosing requirement, which some patients find less convenient than weekly alternatives. However, daily injections allow for more gradual dose adjustments, which may suit patients sensitive to gastrointestinal side effects [4].

Both medications are licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 with weight-related comorbidities. Your UK prescriber will recommend the most appropriate option based on your lifestyle preferences, previous medication responses, and clinical profile [2][4].

Wegovy Oral Tablets: A New Alternative

Cured Pharmacy now offers Wegovy oral tablets (semaglutide pill) from £135.00 providing a non-injectable alternative for patients who prefer oral medication. The tablet formulation contains the same active ingredient as Wegovy injections and requires once-daily dosing with water on an empty stomach [5].

Orlistat-Based Treatments: Lower-Cost Weight Loss Options

For patients seeking more affordable weight loss medication, orlistat-based treatments offer clinically proven efficacy at lower price points. Orlistat works differently from GLP-1 injections — it blocks approximately 25% of dietary fat absorption in the intestines rather than affecting appetite hormones [6].

At Cured Pharmacy, prescription-strength Orlistat 120mg starts from £135.00 Xenical (branded orlistat) from £135.00, and over-the-counter Alli 60mg from £135.00. Clinical trials showed patients using orlistat alongside dietary changes lost an average of 5-10% body weight over 12 months — modest compared to injectable GLP-1 treatments but achieved at significantly lower cost [6].

Orlistat requires three times daily dosing with meals and works best when combined with a reduced-calorie, lower-fat diet. Common side effects relate to unabsorbed fat passing through the digestive system, which typically diminishes as patients adapt their dietary fat intake. UK prescribers often recommend orlistat as a first-line option for patients with lower BMI thresholds or those preferring oral medication [6].

What's Included in Weight Loss Injection Cost UK Pricing at Cured Pharmacy

Our transparent pricing model includes several services beyond the medication itself. Every weight loss injection purchase includes a free online consultation with a UK-registered prescriber, typically completed in under three minutes through our secure clinical assessment platform. There are no hidden consultation fees or subscription charges [7].

All medications are dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We provide discreet packaging with no external branding, next-day delivery options, and ongoing clinical support throughout your treatment journey [7].

Unlike some providers who advertise low headline prices but add consultation fees, prescription charges, or delivery costs at checkout, Cured Pharmacy displays the complete treatment cost upfront. This transparency allows you to compare weight loss injection cost UK pricing accurately across providers and make informed financial decisions about your care [7].

Prescription Requirements and Clinical Assessment

All injectable weight loss medications are prescription-only medicines in the UK and require clinical assessment by a registered prescriber before dispensing. Our online consultation collects your medical history, current medications, and weight management goals to ensure safe, appropriate prescribing in line with MHRA and NICE guidance [7].

Maximising Value: Clinical Considerations Beyond Price Alone

Whilst comparing weight loss injection cost UK pricing is important, clinical suitability and expected outcomes should guide your treatment choice. A lower-cost medication that produces minimal results may represent poorer value than a higher-priced option with greater efficacy for your specific circumstances [1][2].

Research shows that adherence rates differ significantly between daily and weekly injections, with weekly formulations showing approximately 30% better long-term compliance in real-world studies. This improved adherence often translates to better clinical outcomes, potentially justifying higher upfront costs through superior results [8].

Your UK prescriber will discuss realistic weight loss expectations, potential side effects, and treatment duration requirements during your consultation. Most patients require 6-12 months of treatment to achieve optimal results, so understanding the total programme cost rather than single-purchase pricing provides a more accurate financial picture. Cured Pharmacy offers ongoing prescriptions at consistent pricing with no price increases for established patients [8].

Supporting Your Weight Loss Journey

Successful weight management extends beyond medication alone. We recommend combining your prescribed treatment with dietary modifications, increased physical activity, and behavioural support. The NHS provides free resources through local weight management services, and your GP can refer you to specialist programmes if appropriate [8].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Knop, F. K., Aroda, V. R., do Vale, R. D., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10403), 705–719. https://doi.org/10.1016/S0140-6736(23)01185-6 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC. https://www.pharmacyregulation.org/standards [accessed 13 August 2026]
8. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals, and outcomes described in clinical trials represent average responses under controlled conditions.